Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Cost-effectiveness and budget impact analyses of a colorectal cancer screening programme in a high adenoma prevalence scenario using MISCAN-Colon microsimulation model

Fig. 1

Adenomas Prevalence Observed in COLONPREV study and other published studies Versus Simulated by MISCAN-Colon (% of individuals with adenomas)*. a) Men; b) Women. *Observed results are only shown for the two largest studies on which the model has been calibrated. MISCAN-Colon has additionally been calibrated to 8 other autopsy studies

Back to article page